Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3
The experimentally established mechanism targets of Carvedilol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 8/20 | 1.00 |
| ▸ | ADRB1 known ✓ | P08588 | 1/20 | 1.00 |
| ▸ | ADRB3 known ✓ | P13945 | 1/20 | 1.00 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 1.00 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | TLR4 | O00206 | 2/20 | 1.00 |
| ▸ | DNM1 | Q05193 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | SLC22A2 | O15244 | 1/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | KCNK2 | O95069 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16549969 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| (R)-Carvedilol SCHEMBL29382761 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| Carvedilol SCHEMBL29370188 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| Carvedilol SCHEMBL29687280 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| Carvedilol SCHEMBL29744884 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| Carvedilol SCHEMBL1560204 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| (R)-Carvedilol SCHEMBL29744872 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| (R)-Carvedilol SCHEMBL232110 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| Carvedilol SCHEMBL10082334 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 | |
| Carvedilol SCHEMBL1172788 | 1.00 | ADRB2 (1.00) | ADRB2DRD2MAPTTLR4DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 33866 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| CN-116824393-B | Lake chlorophyll inversion method based on migration learning and semi-supervised regression model | 吉林大学 | 2026-05-15 | — | — | CN | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260115166-A1 | COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PHOTORECEPTOR ROD DEGENERATIONS AND GENERATION OF PHOTORECEPTORS | PURDUE RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | claimed |
| EP-4727545-A2 | COMBINATION TREATMENTS FOR DEPRESSION AND OTHER DISORDERS | Neurawell Therapeutics (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-3746081-B1 | PDE1 INHIBITORS FOR USE TO TREAT CARDIAC FAILURE AND CARDIOTOXICITY | INTRA CELLULAR THERAPIES INC (US) | 2026-04-01 | — | — | EP | claimed |
| US-20260076953-A1 | METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-03-19 | — | — | US | claimed |
| US-20260069555-A1 | Compositions and Methods for Modulating the Effect of Beta-Blocker Activity in a Subject | UNIV DUKE (US) | 2026-03-12 | — | — | US | claimed |
| US-12550885-B2 | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells | UNIVERSITY OF CINCINNATI (US) | 2026-02-17 | — | — | US | claimed |
| US-5453436-A | Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanolamine compounds | BOEHRINGER MANNHEIM PHARMACEUTICAL CORPORATION (US) | 1995-09-26 | — | — | US | claimed |
| EP-0648118-A1 | METHODS AND PRODUCTS FOR TREATING PRESBYOPIA | TELOR OPHTHALMIC PHARMACEUTICALS, INC. (US) | 1995-04-19 | — | — | EP | claimed |
| US-5399581-A | Method and compositions for treatment of sexual impotence | LARAGH JOHN H (US) | 1995-03-21 | — | — | US | claimed |
| EP-0625903-A1 | TOPICAL ANTIGLAUCOMA COMPOSITIONS COMPRISING CARBONIC ANHYDRASE INHIBITORS AND BETA-BLOCKERS | ALCON LABORATORIES, INC. (US) | 1994-11-30 | — | — | EP | claimed |
| WO-1994020097-A1 | USE OF, AND METHOD OF TREATMENT USING, CARBAZOLYL-(4)-OXYPROPANOLAMINE COMPOUNDS FOR INHIBITION OF SMOOTH MUSCLE CELL PROLIFERATION | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION-SMITHKLINE BEECHAM CORPORATION LIMITED PARTNERSHIP NO. 1 (US) | 1994-09-15 | — | — | WO | claimed |
| WO-1994020096-A1 | METHOD OF EMPLOYING CARBAZOLYL-(4)-OXYPROPANOLAMINE COMPOUNDS FOR INHIBITION OF SMOOTH MUSCLE CELL PROLIFERATION | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION - SMITHKLINE BECKMAN CORPORATION LIMITED (US) | 1994-09-15 | — | — | WO | claimed |
| US-5308862-A | Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION - SMITHKLINE BEECHAM CORP., LTD. PARTNERSHIP NO. 1 (US) | 1994-05-03 | — | — | US | claimed |
| WO-1994001096-A1 | METHODS AND PRODUCTS FOR TREATING PRESBYOPIA | TELOR OPHTHALMIC PHARMACEUTICALS, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| WO-1993016701-A2 | TOPICAL ANTIGLAUCOMA COMPOSITIONS COMPRISING CARBONIC ANHYDRASE INHIBITORS AND BETA-BLOCKERS | ALCON LABORATORIES, INC. (US) | 1993-09-02 | — | — | WO | claimed |
| WO-1992011851-A1 | METHOD AND COMPOSITIONS FOR TREATMENT OF SEXUAL IMPOTENCE | LARAGH JOHN H (US) | 1992-07-23 | — | — | WO | claimed |